Published on 30/11/2025

Independent Technical Review: When and How to Use It

Introduction to Independent Technical Reviews

In the pharmaceutical industry, compliance with regulatory standards is paramount for maintaining product quality and patient safety. Independent Technical Reviews (ITRs) serve as a crucial mechanism for ensuring that technical processes, changes, and procedures comply with the stringent requirements set forth by regulatory bodies such as the FDA, EMA, and MHRA. This article will guide you through the steps of conducting Independent Technical Reviews, particularly as they relate to change control impact assessments.

ITRs are typically employed during the change control process when changes may impact product quality, safety, or efficacy. By utilizing ITRs, organizations can help mitigate risk while enhancing the robustness of their quality management systems. This tutorial will cover the essentials of conducting an ITR, focusing on the procedures for risk assessment and compliance with guidelines such as Annex 15 and 21 CFR Part 211.

Understanding Change Control and Its Importance

The change control process is integral to the quality management systems in pharmaceutical organizations. It is the method by which companies manage and document changes to processes, materials, or equipment that could potentially impact product quality. A robust change control system helps ensure that any changes made are evaluated for their impact on quality and regulatory compliance.

When evaluating the impact of changes, organizations must utilize change control impact assessment tools that integrate risk management principles. This is where independent technical reviews come into play, as they provide an additional layer of scrutiny to assess whether potential changes align with established risk thresholds.

Step 1: Defining the Scope of the Technical Review

The first step in conducting an ITR is defining the scope of the review. This involves identifying the specific changes or proposals that will be evaluated. Factors to consider include:

• Nature of the change (process change, material change, equipment change)
• Potential impact on quality and regulatory compliance
• Relevant regulations and guidance documents (e.g., Annex 15, 21 CFR Part 211)

Clearly defining the scope helps to ensure that all potential consequences of the change are evaluated, allowing for a comprehensive risk assessment.

Step 2: Gathering Relevant Documentation and Evidence Packs

Once the scope has been defined, the next step is to collect and review relevant documentation. This documentation may include:

• Change control proposals
• Historical data regarding similar changes
• Current quality and compliance metrics
• Evidence packs that support the proposed change

Evidence packs play a crucial role in the ITR process, as they provide the technical justification for the change and offer data supporting the effectiveness of the proposed actions. It is essential to collate comprehensive data to facilitate informed decision-making during the review.

Step 3: Conducting a Risk Assessment

Once the documentation has been gathered, the next phase is conducting a thorough risk assessment. The aim of the risk assessment is to quantify the potential impact of the change on product quality and compliance. This process typically involves creating a risk analysis framework or utilizing an existing framework that aligns with regulatory expectations.

Key elements of the risk assessment should include:

• Identification of potential risks associated with the change
• Risk analysis to determine the severity and likelihood of identified risks
• Development of a risk matrix to assess the overall risk level

Employing a risk-based change threshold helps determine whether further validation or a bridging study is necessary. For instance, if a proposed change falls within acceptable risk limits (e.g., cpv limits), it may proceed with less scrutiny.

Step 4: Evaluating Verification vs Re-Validation Requirements

One critical consideration during the independent technical review is understanding the difference between verification and re-validation. Verification focuses on assessing whether a given process, procedure, or result meets predetermined criteria, whereas re-validation entails comprehensive testing to confirm that a system or process remains in a validated state following a change.

Determining whether verification or re-validation is appropriate depends on the significance of the change and its potential impact on product quality. If an ITR reveals that a change has introduced new variables that could affect outcomes, re-validation may be necessary. Conversely, minor changes that do not significantly impact product quality may warrant verification alone.

Step 5: Approving the Change or Recommending Mitigation Measures

Following the risk assessment and determination of verification versus re-validation requirements, a decision must be made on the proposed change. This could result in one of several outcomes:

• Approval of the proposed change without further actions
• Approval contingent upon specific mitigative actions being taken
• Rejection of the proposed change due to unacceptable risk factors

It is important for the final recommendation to be documented adequately, including justification for the decision made. This serves as an essential record for future audits and regulatory inspections, demonstrating compliance with change control and risk assessment processes.

Step 6: Implementing Change and Conducting Effectiveness Checks

Upon approval of the change, the implementation phase can commence. It is critical to ensure that all stakeholders are informed and that any necessary training is conducted. Following implementation, organizations should conduct effectiveness checks to verify that the change has achieved its intended outcomes while maintaining adherence to quality standards.

Effectiveness checks may involve:

• Reviewing process performance metrics post-implementation
• Monitoring product quality indicators
• Conducting periodic reviews as outlined in governing regulations

The results of these checks should be documented to provide data for future evaluations and can serve as evidence of compliance during inspections.

Bridging Studies and Validation Strategies

In scenarios where significant changes occur, bridging studies may be necessary to assess the impact on product quality and performance. A bridging study is an essential validation strategy that compares results from the original process to those of the modified process. It helps establish a confidence level that the new process meets predefined acceptance criteria.

Planning and execution of bridging studies should include:

• Defining the objectives of the study
• Determining the acceptance criteria
• Selecting a representative sampling plan

Bridging studies can significantly reduce risk by providing comparative analyses that validate changes, ensuring that quality remains consistent even with modifications in processes or materials.

Conclusion: Continuous Improvement and Quality Compliance

Independent Technical Reviews are fundamental to maintaining rigorous change control processes in the pharmaceutical industry. By following a structured approach that includes risk assessment, verification versus re-validation assessments, and systematic documentation, organizations can navigate complexities in regulatory compliance while fostering an environment of continuous improvement.

Establishing a robust framework for conducting ITRs ensures that companies can adapt to change while safeguarding product quality, safety, and efficacy—fulfilling the expectations of regulators and patients alike. For additional guidance on related regulatory frameworks, refer to documents from the EMA, including Annex 15 and 21 CFR Part 211.